A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults.

M, Nissen; H, Marshall; P, Richmond; S, Shakib; Q, Jiang; D, Cooper; D, Rill; J, Baber; J, Eiden; W, Gruber; KU, Jansen; EA, Emini; AS, Anderson; ET, Zito; D, Girgenti

doi:10.1016/j.vaccine.2015.02.024

Public

A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults.

Shared by NobleBlocks on Feb 21, 2015 • 12:00 AM UTC

Authors:

Nissen M

Marshall H

Richmond P

Abstract

<h4>Background</h4>Staphylococcus aureus is a common cause of healthcare-acquired morbidity and mortality and increased healthcare resource utilization. A prophylactic vaccine is being developed that may reduce this disease burden.<h4>Methods</h4>Volunteers in good general health aged 50-85 (n=312) ...

Subject

Staphylococcus aureus

Vaccine

Functional Antibodies

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!